-- Primaris房地产投资信托基金（PMZ-UN.TO）周三盘后公布，第一季度总租赁收入和利润均有所增长，并重申了其2026年的业绩展望。 该房地产投资信托基金第一季度盈利4190万美元，合每单位0.305美元，高于去年同期的3120万美元，合每单位0.257美元。FactSet的相应数据暂未公布。 总租赁收入从去年同期的1.502亿美元增至1.7704亿美元。FactSet此前预计销售额为1.808亿美元。 Primaris还指出，平均稀释后单位运营资金（FFO）为0.425美元，高于去年同期的0.439美元。FactSet此前预计每股FFO为0.44美元。 “我们低杠杆、低派息率的模式是我们战略的关键支柱。我们拥有充足的流动性，无担保信贷额度可全额使用，且2026年没有债务到期，”首席财务官拉格斯·达夫洛尔 (Rags Davloor) 表示。 “凭借强劲的流动性、极低的杠杆率和低派息率，我们能够更好地为内部增长提供资金，提升投资组合质量，并为我们的单位持有人创造长期价值，”首席执行官亚历克斯·艾弗里 (Alex Avery) 补充道。 该房地产投资信托基金 (REIT) 表示，将维持其2026年全年业绩指引。 该REIT的单位在多伦多证券交易所收盘下跌0.05美元，至18.98美元。
Related Articles
Asia
Electro Optic Systems Reports Contract Backlog Growth as of March 31
Electro Optic Systems Holdings (ASX:EOS) reported a contract backlog of AU$518 million as of March 31, up 13% from the end of 2025, according to a Thursday filing with the Australian bourse.The company closed the March quarter with unrestricted cash holdings of AU$95.1 million, representing a decrease of AU$11.8 million from the end of 2025, per the filing.
$ASX:EOS
Asia
Regis Healthcare Expects Fiscal 2026 Underlying EBITDA at Top End of Guidance
Regis Healthcare (ASX:REG) said it expects fiscal 2026 underlying earnings before interest, taxes, depreciation, and amortization (EBITDA) of about AU$135 million, at the top end of guidance, according to a Thursday Australian bourse filing.Occupancy across mature homes averaged about 96% in the fiscal third quarter, per the filing.The company said it generated net refundable accommodation deposit (RAD) cash inflows of AU$44.5 million in the third quarter, taking the total net RAD cash inflows for the year to date to AU$223 million.As resident turnover occurs, the progressive repricing of existing paid-up RADs to current advertised room prices is expected to generate net operating cash inflows of about AU$400 million over time while also increasing RAD retention earnings, the company added.
$ASX:REG
Research
Research Alert: CFRA Keeps Hold Opinion On Shares Of Mondelez International
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Our 12-month target price of $63, raised $1, reflects a 19x multiple of projected 2027 EPS, in line with MDLZ's historical forward P/E average. We raise our 2026 EPS estimate by $0.06 to $3.08, but cut 2027's by $0.11 to $3.32. We continue to see headwinds related to chocolate and biscuits divisions, though favorable forex has been helping to a degree. MDLZ highlighted plans to stimulate growth with more promotional activity, which could boost revenues (we see an acceleration in revenues in 2027), but may come with the trade-off of narrower margins. We note that cost-saving efforts can also contribute to staving off some of the margin pressure. MDLZ is largely hedged on its cocoa input costs for 2026 but less so in 2027. Thus, if the substantial rise in cocoa pricing in 2025 does not reemerge, it should help the bottom line in 2027 as cost pressures should ease. Share buybacks have also contributed to EPS, and we note that Q1 2026 share count was down 1.5% from one year earlier.
$MDLZ